Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ProPhase Labs Debt to Equity Ratio 2010-2025 | PRPH

Current and historical debt to equity ratio values for ProPhase Labs (PRPH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ProPhase Labs debt/equity for the three months ending June 30, 2025 was 0.20.
  
ProPhase Labs Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-06-30 $0.03B $0.01B 2.68
2025-03-31 $0.04B $0.02B 2.32
2024-12-31 $0.06B $0.01B 7.60
2024-09-30 $0.05B $0.04B 1.41
2024-06-30 $0.05B $0.04B 1.13
2024-03-31 $0.05B $0.05B 1.01
2023-12-31 $0.04B $0.05B 0.86
2023-09-30 $0.04B $0.06B 0.63
2023-06-30 $0.03B $0.06B 0.54
2023-03-31 $0.04B $0.06B 0.59
2022-12-31 $0.02B $0.06B 0.38
2022-09-30 $0.03B $0.07B 0.44
2022-06-30 $0.03B $0.07B 0.44
2022-03-31 $0.03B $0.07B 0.50
2021-12-31 $0.03B $0.06B 0.52
2021-09-30 $0.02B $0.05B 0.51
2021-06-30 $0.03B $0.05B 0.60
2021-03-31 $0.03B $0.05B 0.62
2020-12-31 $0.02B $0.01B 1.98
2020-09-30 $0.01B $0.01B 1.14
2020-06-30 $0.00B $0.01B 0.14
2020-03-31 $0.00B $0.01B 0.12
2019-12-31 $0.00B $0.01B 0.09
2019-09-30 $0.00B $0.01B 0.08
2019-06-30 $0.00B $0.02B 0.08
2019-03-31 $0.00B $0.02B 0.06
2018-12-31 $0.00B $0.02B 0.26
2018-09-30 $0.00B $0.02B 0.04
2018-06-30 $0.00B $0.02B 0.08
2018-03-31 $0.00B $0.03B 0.06
2017-12-31 $0.00B $0.03B 0.06
2017-09-30 $0.00B $0.04B 0.09
2017-06-30 $0.00B $0.05B 0.09
2017-03-31 $0.01B $0.05B 0.15
2016-12-31 $0.01B $0.01B 1.15
2016-09-30 $0.01B $0.01B 0.96
2016-06-30 $0.01B $0.01B 0.81
2016-03-31 $0.01B $0.01B 0.78
2015-12-31 $0.01B $0.01B 0.68
2015-09-30 $0.00B $0.01B 0.38
2015-06-30 $0.00B $0.01B 0.44
2015-03-31 $0.01B $0.01B 0.60
2014-12-31 $0.01B $0.01B 0.50
2014-09-30 $0.01B $0.01B 0.70
2014-06-30 $0.01B $0.01B 0.45
2014-03-31 $0.00B $0.01B 0.35
2013-12-31 $0.01B $0.01B 0.38
2013-09-30 $0.01B $0.01B 0.43
2013-06-30 $0.01B $0.01B 0.46
2013-03-31 $0.00B $0.01B 0.35
2012-12-31 $0.01B $0.01B 0.46
2012-09-30 $0.01B $0.01B 0.67
2012-06-30 $0.01B $0.01B 0.73
2012-03-31 $0.01B $0.01B 0.69
2011-12-31 $0.01B $0.01B 0.70
2011-09-30 $0.01B $0.01B 0.59
2011-06-30 $0.01B $0.01B 0.48
2011-03-31 $0.01B $0.01B 0.59
2010-12-31 $0.01B $0.01B 0.61
2010-09-30 $0.01B $0.01B 0.54
2010-06-30 $0.01B $0.01B 0.47
2010-03-31 $0.01B $0.02B 0.42
2009-12-31 $0.01B $0.01B 0.52
2009-09-30 $0.01B $0.01B 0.48
2009-06-30 $0.01B $0.01B 0.50
2009-03-31 $0.01B $0.02B 0.39
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.013B $0.007B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $72.337B 27.82
Zoetis (ZTS) United States $68.990B 25.03
Daiichi Sankyo, - (DSNKY) Japan $51.110B 26.19
Takeda Pharmaceutical (TAK) Japan $48.365B 9.87
BeOne Medicines - (ONC) Switzerland $34.251B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.677B 0.00
Summit Therapeutics (SMMT) United States $18.831B 0.00
Merck (MKKGY) Germany $16.743B 10.89
Shionogi (SGIOY) Japan $15.067B 15.10
United Therapeutics (UTHR) United States $14.128B 12.23
Neurocrine Biosciences (NBIX) United States $13.172B 39.29
Orion OYJ (ORINY) Finland $11.248B 27.11
IPSEN (IPSEY) France $11.218B 0.00
Eisai (ESAIY) $9.356B 10.55
Madrigal Pharmaceuticals (MDGL) United States $8.427B 0.00
Corcept Therapeutics (CORT) United States $7.396B 62.12
Grifols, S.A (GRFS) Spain $7.006B 0.00
Stevanato Group S.p.A (STVN) Italy $6.799B 40.09
Ionis Pharmaceuticals (IONS) United States $6.771B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.355B 18.39
Soleno Therapeutics (SLNO) United States $3.551B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.930B 13.93
Crinetics Pharmaceuticals (CRNX) United States $2.772B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.754B 0.00
Hypermarcas (HYPMY) Brazil $2.678B 20.13
Catalyst Pharmaceuticals (CPRX) United States $2.478B 8.30
Centessa Pharmaceuticals (CNTA) United Kingdom $2.322B 0.00
Ocular Therapeutix (OCUL) United States $2.112B 0.00
Dyne Therapeutics (DYN) United States $1.743B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.738B 0.00
Guardian Pharmacy Services (GRDN) United States $1.607B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.584B 23.59
Harrow (HROW) United States $1.415B 0.00
Ardelyx (ARDX) United States $1.412B 0.00
ARS Pharmaceuticals (SPRY) United States $1.363B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.330B 0.00
Evotec AG (EVO) Germany $1.282B 0.00
Xeris Biopharma Holdings (XERS) United States $1.188B 0.00
Collegium Pharmaceutical (COLL) United States $1.185B 6.48
Enliven Therapeutics (ELVN) United States $1.170B 0.00
Cronos Group (CRON) Canada $0.950B 0.00
Akebia Therapeutics (AKBA) United States $0.806B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.698B 7.20
Amylyx Pharmaceuticals (AMLX) United States $0.697B 0.00
ProKidney (PROK) United States $0.682B 0.00
Theravance Biopharma (TBPH) United States $0.677B 56.04
KalVista Pharmaceuticals (KALV) United States $0.640B 0.00
Siga Technologies (SIGA) United States $0.628B 7.76
Elite Pharmaceuticals (ELTP) United States $0.611B 0.00
Bioventus (BVS) United States $0.605B 14.64
Relay Therapeutics (RLAY) United States $0.586B 0.00
Tourmaline Bio (TRML) United States $0.575B 0.00
Organogenesis (ORGO) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.566B 11.59
Oruka Therapeutics (ORKA) United States $0.545B 0.00
Xencor (XNCR) United States $0.541B 0.00
Savara (SVRA) United States $0.527B 0.00
Nektar Therapeutics (NKTR) United States $0.508B 0.00
Zevra Therapeutics (ZVRA) United States $0.506B 0.00
Nanobiotix S.A (NBTX) France $0.431B 0.00
Esperion Therapeutics (ESPR) United States $0.411B 0.00
Aquestive Therapeutics (AQST) United States $0.384B 0.00
Aldeyra Therapeutics (ALDX) United States $0.335B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.320B 0.00
Altimmune (ALT) United States $0.319B 0.00
4D Molecular Therapeutics (FDMT) United States $0.307B 0.00
Larimar Therapeutics (LRMR) United States $0.302B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 19.32
AleAnna (ANNA) United States $0.268B 0.00
OmniAb (OABI) United States $0.248B 0.00
Galectin Therapeutics (GALT) United States $0.240B 0.00
Lyell Immunopharma (LYEL) United States $0.208B 0.00
Heron Therapeutics (HRTX) United States $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.194B 0.00
MediWound (MDWD) Israel $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Korro Bio (KRRO) United States $0.180B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.173B 26.75
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.165B 0.00
Lexeo Therapeutics (LXEO) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.151B 0.00
Profound Medical (PROF) Canada $0.138B 0.00
Achieve Life Sciences (ACHV) Canada $0.131B 0.00
Avita Medical (RCEL) United States $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Avalo Therapeutics (AVTX) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.112B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 23.81
Liminatus Pharma (LIMN) United States $0.100B 0.00
Surrozen (SRZN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
ESSA Pharma (EPIX) Canada $0.090B 0.00
BioNxt Solutions (BNXTF) Canada $0.089B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Nutriband (NTRB) United States $0.069B 0.00
Metagenomi (MGX) United States $0.069B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
DURECT (DRRX) United States $0.058B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.056B 0.00
Karyopharm Therapeutics (KPTI) United States $0.054B 0.00
Rafael Holdings (RFL) United States $0.052B 0.00
Unicycive Therapeutics (UNCY) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 28.00
FibroGen (FGEN) United States $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.043B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.033B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Mural Oncology (MURA) Ireland $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.027B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.02
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
PainReform (PRFX) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.19
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.55
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00